Cooper Laurence James Neil - Net Worth and Insider Trading

Cooper Laurence James Neil Net Worth

The estimated net worth of Cooper Laurence James Neil is at least $148,740 dollars as of 2024-05-12. Cooper Laurence James Neil is the President and CEO of Alaunos Therapeutics Inc and owns about 119,952 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $148,740. Details can be seen in Cooper Laurence James Neil's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cooper Laurence James Neil has not made any transactions after 2021-01-04 and currently still holds the listed stock(s).

Transaction Summary of Cooper Laurence James Neil

To

Cooper Laurence James Neil Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cooper Laurence James Neil owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Cooper Laurence James Neil’s form 4 insider trades.

Insider Ownership Summary of Cooper Laurence James Neil

Ticker Comapny Transaction Date Type of Owner
TCRT Alaunos Therapeutics Inc 2021-01-04 Chief Executive Officer

Cooper Laurence James Neil Latest Holdings Summary

Cooper Laurence James Neil currently owns a total of 1 stock. Cooper Laurence James Neil owns 119,952 shares of Alaunos Therapeutics Inc (TCRT) as of January 4, 2021, with a value of $148,740.

Latest Holdings of Cooper Laurence James Neil

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRT Alaunos Therapeutics Inc 2021-01-04 119,952 1.24 148,740

Holding Weightings of Cooper Laurence James Neil


Cooper Laurence James Neil Form 4 Trading Tracker

According to the SEC Form 4 filings, Cooper Laurence James Neil has made a total of 2 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alaunos Therapeutics Inc is the sale of 7,046 shares on January 4, 2021, which brought Cooper Laurence James Neil around $286,428.

Insider Trading History of Cooper Laurence James Neil

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cooper Laurence James Neil Trading Performance

GuruFocus tracks the stock performance after each of Cooper Laurence James Neil's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cooper Laurence James Neil is -18.22%. GuruFocus also compares Cooper Laurence James Neil's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cooper Laurence James Neil within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cooper Laurence James Neil's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cooper Laurence James Neil

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.14
Relative Return to S&P 500(%) -8.34

Cooper Laurence James Neil Ownership Network

Ownership Network List of Cooper Laurence James Neil

No Data

Ownership Network Relation of Cooper Laurence James Neil


Cooper Laurence James Neil Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Cooper Laurence James Neil is the Chief Executive Officer of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Cooper Laurence James Neil made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net purchase of 1,250,000 shares made by Jaime Vieser , a net purchase of 750,000 shares made by Robert W Postma , and a net sale of 68,014 shares made by Boyle Kevin S. Sr. .

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 133,333 shares were bought by its insiders, resulting in a net purchase of 128,799 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alaunos Therapeutics Inc Insider Transactions

No Available Data

Cooper Laurence James Neil Mailing Address

Above is the net worth, insider trading, and ownership report for Cooper Laurence James Neil. You might contact Cooper Laurence James Neil via mailing address: C/o Ziopharm Oncology, Inc., 1 First Ave, Parris Building #34, Boston Ma 02129.

Discussions on Cooper Laurence James Neil

No discussions yet.